Literature DB >> 15031789

Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda.

Ronald H Gray1, X Li, Maria J Wawer, David Serwadda, Nelson K Sewankambo, Fred Wabwire-Mangen, Tom Lutalo, Noah Kiwanuka, Godfrey Kigozi, Fred Nalugoda, Mary P Meehan, Merlin Robb, Thomas C Quinn.   

Abstract

Human immunodeficiency virus (HIV) type 1 RNA loads were determined for 256 subjects with early (incident) HIV infection and for 1293 subjects with later (prevalent) HIV infection, in a Ugandan cohort. Prevalent infections were classified as latent (0-1 symptoms) and midstage disease (>/=2 symptoms), and deaths were ascribed to acquired immunodeficiency syndrome. Among subjects with incident HIV infection, HIV load did not differ by sex, but, among subjects with prevalent HIV infection, it was higher in males than in females. HIV load was highest in subjects (25-29 years old) with incident HIV infection but increased with age in subjects with prevalent HIV infection. Viremia was higher after serconversion than in latency and increased with more advanced disease. Viremia was increased with genital ulcer disease (GUD) in both subjects with incident infection and in those with prevalent infection, and with herpes simplex virus type 2 seropositivity in subjects with incident HIV infection. GUD was consistently associated with higher HIV loads in subjects with incident and those with prevalent HIV infection, suggesting that treatment of GUD might reduce HIV viremia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031789     DOI: 10.1086/382750

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Authors:  Alison L Drake; Alison C Roxby; Francisca Ongecha-Owuor; James Kiarie; Grace John-Stewart; Anna Wald; Barbra A Richardson; Jane Hitti; Julie Overbaugh; Sandra Emery; Carey Farquhar
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

2.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.

Authors:  H Nina Kim; Jing Wang; James Hughes; Robert Coombs; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Jonathan Fuchs; Susan H Eshleman; Leila Khaki; Moira A McMahon; Robert F Siliciano; Anna Wald; Connie Celum
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

3.  Gender differences in the prevalence of sexually transmitted infections and genital symptoms in an urban setting in southern India.

Authors:  S Panchanadeswaran; S C Johnson; K H Mayer; A K Srikrishnan; S Sivaran; C E Zelaya; V F Go; S Solomon; M E Bentley; D D Celentano
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

4.  Efforts to Control Sexually Transmitted Infections As a Means to Limit HIV Transmission: What Is the Evidence?

Authors:  Gina Dallabetta; Graham Neilsen
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

Review 5.  Efforts to control sexually transmitted infections as a means to limit HIV transmission: what is the evidence?

Authors:  Gina Dallabetta; Graham Neilson
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

6.  Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

Authors:  Diane M Janowicz; Klara Tenner-Racz; Paul Racz; Tricia L Humphreys; Carol Schnizlein-Bick; Kate R Fortney; Beth Zwickl; Barry P Katz; James J Campbell; David D Ho; Stanley M Spinola
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

7.  Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Authors:  J Lingappa; E Nakku-Joloba; A Magaret; D Friedrich; J Dragavon; F Kambugu; M Joloba; C Whalen; R Coombs; C Celum; R Ashley Morrow
Journal:  Int J STD AIDS       Date:  2010-09       Impact factor: 1.359

8.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

9.  Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.

Authors:  Esra Fakioglu; Sarah S Wilson; Pedro M M Mesquita; Ehsan Hazrati; Natalia Cheshenko; John A Blaho; Betsy C Herold
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

Review 10.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.